These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 14625577

  • 1. Effect of allogeneic stem cell transplantation on bone marrow angiogenesis in chronic myelogenous leukemia.
    Kumar S, Litzow MR, Rajkumar SV.
    Bone Marrow Transplant; 2003 Dec; 32(11):1065-9. PubMed ID: 14625577
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS, Kumar L, Dinda AK, Dawar R.
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [Abstract] [Full Text] [Related]

  • 3. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.
    Kumar S, Gertz MA, Dispenzieri A, Lacy MQ, Wellik LA, Fonseca R, Lust JA, Witzig TE, Kyle RA, Greipp PR, Rajkumar SV.
    Bone Marrow Transplant; 2004 Aug; 34(3):235-9. PubMed ID: 15170170
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK, Parikh PM, Tawde S, Amare-Kadam PS, Rajadhyaksha S, Chhaya S.
    Natl Med J India; 2004 Aug; 17(2):71-3. PubMed ID: 15141598
    [Abstract] [Full Text] [Related]

  • 6. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E, Koza V, Vítek A, Mayer J, Sedlácek P, Zák P, Zapletalová J, Benesová K, Krejcová H, Steinerová K, Maresová I, Cetkovský P.
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [Abstract] [Full Text] [Related]

  • 7. [Study on the role of angiogenesis and related factors in leukemias].
    Zhang Y, Gu J, Wang M, Ma L, Wang XL, He B, Sun M.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):175-8. PubMed ID: 15946533
    [Abstract] [Full Text] [Related]

  • 8. [Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].
    Qin YZ, Li JL, Zhu HH, Ruan GR, Li LD, Zhang Y, Xu LP, Liu DH, Liu YR, Huang XJ, Chen SS, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):511-4. PubMed ID: 17172121
    [Abstract] [Full Text] [Related]

  • 9. Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia.
    Koldehoff M, Beelen DW, Trenschel R, Steckel NK, Peceny R, Ditschkowski M, Ottinger H, Elmaagacli AH.
    Bone Marrow Transplant; 2004 Dec; 34(12):1047-50. PubMed ID: 15516946
    [Abstract] [Full Text] [Related]

  • 10. [HLA-identical sibling allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia in first chronic phase. Analysis of 51 cases].
    He Y, Feng SZ, Wang M, Wei JL, Qin TJ, Zhou Z, Zhai WJ, Qiu LG, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):389-92. PubMed ID: 16251016
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study.
    Korkolopoulou P, Viniou N, Kavantzas N, Patsouris E, Thymara I, Pavlopoulos PM, Terpos E, Stamatopoulos K, Plata E, Anargyrou K, Androulaki A, Davaris P, Yataganas X.
    Leukemia; 2003 Jan; 17(1):89-97. PubMed ID: 12529665
    [Abstract] [Full Text] [Related]

  • 12. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment.
    Simon W, Segel GB, Lichtman MA.
    Blood Cells Mol Dis; 2006 Jan; 37(2):116-24; discussion 125-7. PubMed ID: 16904348
    [Abstract] [Full Text] [Related]

  • 13. Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patients.
    Thiele J, Kvasnicka HM, Beelen DW, Zirbes TK, Jung F, Reske D, Leder LD, Schaefer UW.
    Bone Marrow Transplant; 2000 Aug; 26(3):275-81. PubMed ID: 10967565
    [Abstract] [Full Text] [Related]

  • 14. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [Abstract] [Full Text] [Related]

  • 15. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry.
    Nivison-Smith I, Bradstock KF, Dodds AJ, Hawkins PA, Szer J.
    Intern Med J; 2005 Jan; 35(1):18-27. PubMed ID: 15667464
    [Abstract] [Full Text] [Related]

  • 16. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A, Brand R, Apperley J, Crawley C, Ruutu T, Corradini P, Carreras E, Devergie A, Guglielmi C, Kolb HJ, Niederwieser D, Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723
    [Abstract] [Full Text] [Related]

  • 17. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
    Panteli K, Zagorianakou N, Bai M, Katsaraki A, Agnantis NJ, Bourantas K.
    Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
    [Abstract] [Full Text] [Related]

  • 18. Autologous transplantation in chronic myelogenous leukemia: European results: Chronic Leukemia Working Party of the EBMT.
    Reiffers J, Goldman J, Meloni G, Cahn JY, Faberes C, Apperley J.
    Bone Marrow Transplant; 1994 Jun; 14 Suppl 3():S51-4. PubMed ID: 7697010
    [Abstract] [Full Text] [Related]

  • 19. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
    Novotny JR, Rosenthal C, Elmaagacli AH, Dürig J, Beelen DW, Dührsen U.
    Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow transplant in Ph+ ALL patients.
    Avivi I, Goldstone AH.
    Bone Marrow Transplant; 2003 Apr; 31(8):623-32. PubMed ID: 12692601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.